President Trump shared an anecdote about a wealthy friend’s experience with inflated drug prices in the U.S., prompting a drug company executive to admit to overcharging Americans. This occurred as Trump signed an executive order aimed at drastically reducing pharmaceutical costs by aligning them with international prices.